Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
UC Davis has received a $420,500 donation from the Susan and Charles Berghoff Foundation, with additional support from William Ballhaus and Darrin Mollett, to fund AggieBrain, an AI initiative that advances digital neuropathology research for dementia.
PartsSource has acquired SkillNet, a workforce intelligence platform for healthcare technology management, expanding its Enterprise Clinical Technology platform to include workforce readiness and training capabilities.
Cambridge-based Ambitious Bio has emerged from stealth, introducing a new approach to generating large-scale biological datasets designed for AI model training and disease research.
UCB is consolidating its global pharmacovigilance operations using Veeva Safety Suite to improve efficiency, standardize workflows, and enhance data management across its safety processes.
SciBase and Castle Biosciences have enrolled the first patient in a clinical study evaluating the use of electrical impedance spectroscopy to predict flare-ups in atopic dermatitis.
Photocure and Artera have launched a joint research initiative to evaluate the ArteraAI Bladder Test using data from Photocure’s blue light cystoscopy registry, aiming to improve diagnostic precision for bladder cancer.
Visage Imaging will highlight its AI optimized One Platform and the latest version of Visage 7 at the SIIM 2026 annual meeting in Pittsburgh, featuring new reporting and digital pathology capabilities.
FinThrive has introduced Denials Prevention Manager, an AI solution that predicts and prevents claim denials before submission by analyzing historical claims data and payer behavior.
PointClickCare has added new AI capabilities to its PAC Management solution to improve discharge planning from skilled nursing facilities, giving hospitals, health plans, and ACOs greater visibility into patient transitions.
Careviso has expanded its national physician and provider network to more than 460,000 enrollments, with plans to exceed 500,000 by the end of 2026. The company also introduced new enhancements to its seeQer platform to improve prior authorization efficiency.
LinkedIn co-founder Reid Hoffman will step down from Microsoft's board at the end of the year to dedicate his time to his new AI biopharmaceutical company, Manas.
The Digital Health Measurement Collaborative Community (DATAcc) by the Digital Medicine Society (DiMe) has introduced the first digital measures set designed for common mental health disorders. The release provides standardized tools for researchers, clinicians, and developers to assess treatment effects and patient outcomes using sensor-based data.
Fullspan Health has launched Healthline AI, a conversational health agent that provides medically reviewed information and guidance to consumers on Healthline.com. The tool features clinical guardrails, privacy protections, and triage protocols to help users make informed health decisions.
Insilica CEO Dr. Thomas Luechtefeld has co-authored a new framework called Evidence-based AI, introducing rigorous standards for AI systems in toxicology.
TFC Taipei Fertility Center in Taiwan has introduced an AI-based embryo assessment model that increases the accuracy of identifying chromosomally normal embryos by up to 24 percent, according to a press release. The system, iDAScore v2.0, analyzes time-lapse imaging and data from embryo development to support clinical decisions in IVF treatment.
Microsoft has unveiled seven new MAI models covering reasoning, coding, image generation, transcription, and voice synthesis, while also announcing a collaboration with Mayo Clinic to develop a healthcare-focused AI model.
Lyric Health has announced a partnership with Scala.AI to enhance its healthcare engagement and care navigation platform using AI. The collaboration will focus on improving member engagement, care coordination, and operational efficiency across virtual care services.
Boston Consulting Group announced a $500 million commitment by 2030 to advance AI for social impact, partnering with Anthropic to support non-profits and philanthropies in areas such as education, health care, and poverty reduction.
Compal Electronics unveiled a biotechnology platform that combines quantum computing and artificial intelligence at COMPUTEX 2026, highlighting collaborations with universities and pharmaceutical firms for drug discovery and manufacturing.
Qaelon Medical and Scialytics have formed a partnership to integrate Qaelon's physiologic gastrointestinal data into Scialytics' AI surgical analytics platform, aiming to improve risk detection and surgical outcomes in colorectal procedures.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
